Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorAbeygunasekera, Anuruddha-
Autor(es): dc.creatorJayasinghe, Saroj-
Data de aceite: dc.date.accessioned2026-02-09T12:45:28Z-
Data de disponibilização: dc.date.available2026-02-09T12:45:28Z-
Data de envio: dc.date.issued2020-06-22-
Data de envio: dc.date.issued2020-06-22-
Data de envio: dc.date.issued2020-10-
Fonte completa do material: dc.identifierhttps://repositorio.ufla.br/handle/1/41526-
Fonte completa do material: dc.identifierhttps://www.sciencedirect.com/science/article/pii/S0306987720305636-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1167672-
Descrição: dc.descriptionSARS-CoV-2 virus has resulted in a devastating pandemic of COVID-19. Exploring compounds that could offer a breakthrough in treatment is the need of the hour. Re-positioning cheap, freely available and safe drugs is a priority. The paper proposes evidence for the potential use of diethylcarbamazine (DEC) in the treatment of COVID-19. DEC has inhibitory effects on arachidonic acid metabolism to prostaglandins, little known anti-viral effects on animal retroviruses and demonstrated anti-inflammatory actions in animal models of lung inflammation indicating the need to explore this hypothesis further. We believe this is the first time DEC is being proposed to treat COVID-19.-
Idioma: dc.languageen-
Publicador: dc.publisherElsevier-
Direitos: dc.rightsrestrictAccess-
???dc.source???: dc.sourceMedical Hypotheses-
Palavras-chave: dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-
Palavras-chave: dc.subjectCorona-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectDiethylcarbamazine (DEC)-
Título: dc.titleIs the anti-filarial drug diethylcarbamazine useful to treat COVID-19?-
Tipo de arquivo: dc.typeArtigo-
Aparece nas coleções:Repositório Institucional da Universidade Federal de Lavras (RIUFLA)

Não existem arquivos associados a este item.